Home » Pharma News (page 5)

Pharma News

2016 Nobel Prize in Physiology or Medicine to Yoshinori Ohsumi

2016 Nobel Prize in Physiology or Medicine to Yoshinori Ohsumi The Nobel Prize The Nobel Assembly at Karolinska Institutet has today decided to award the 2016 Nobel Prize in Physiology or Medicine to Yoshinori Ohsumi for his discoveries of mechanisms for autophagy.This year’s Nobel Laureate discovered and elucidated mechanisms underlying autophagy, a fundamental process for degrading and recycling cellular components. ... Read More »

Marksans Pharma rushes on USFDA nod for Loratadine

 Marksans Pharma rushes  on USFDA nod for Loratadine Marksans Pharma has moved higher by 12% to Rs 53.55 on the BSE after the company announced that it has got US drug regulator nod for loratadine liquid filed capsules 10 mg. “The US Food & Drug Administration (USFDA) has granted approval for an Abbreviated New Drug Application (ANDA) for Loratadine liquid ... Read More »

Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Index for the eighth year running

Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Index for the eighth year running For the eighth consecutive year, Roche (SIX: RO, ROG; OTCQX: RHHBY) has been recognised as Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry of the Dow Jones Sustainability Index (DJSI). This is based on an in-depth analysis of economic, ... Read More »

Impurities

Impurities in pharmaceuticals are the unwanted chemicals that remain with the active pharmaceutical ingredients (APIs), or develop during formulation, or upon aging of both API and formulated APIs to medicines. Impurities are substances inside a confined amount of liquid, gas, or solid, which differ from the chemical composition of the material or compound. Impurities are either naturally occurring or added ... Read More »

Pharmaceuticals and Life Sciences

• VIVAN Life Sciences is Knowledge based innovative enterprise, offering higher end level products in Pharmaceuticals and Life Sciences. • We provide break through collaboration for the niche pharmaceutical products, which enhance the capability and productivity performances of our customers and Business Associates, in functions critical to their success. • We stand to lead our Business operations, through innovation, creativity ... Read More »

Severe asthma show positive results by Benralizumab phase III trials

 Severe asthma show positive results by Benralizumab phase III trials  Results from essential Phase III trials introduced at the European Respiratory Society (ERS) International Congress exhibited that adding benralizumab to standard-of-consideration solution altogether diminished intensifications and enhanced lung capacity and asthma side effects in extreme asthma patients with an eosinophilic phenotype, as demonstrated by the nearness of eosinophils in their ... Read More »

Save water Save life

Save water Save life Check and fix any water leaks Don’t wash dishes with the water running continuously. Collect the water you use for rinsing fruits and vegetables, then reuse it to water houseplants Use a commercial car wash that recycles water Take shorter showers to reduce water use Install water-saving devices on your faucets and toilets Instead of throwing ... Read More »

Discovery of a novel Wnt inhibitor with potential to eradicate colorectal cancer stem cells

Discovery of a novel Wnt inhibitor with potential to eradicate colorectal cancer stem cells A team including the National Cancer Center (NCC) (Tokyo, Japan), the RIKEN Center for Life Science Technologies (CLST) (Yokohama, Japan), and Carna Biosciences Inc. (Kobe, Japan) has jointly announced the development of a novel small-molecule Wnt inhibitor named NCB-0846. Wnt signaling is a key pathway of ... Read More »

Agilent investing $120M in new plant to make oligonucleotide APIs

Agilent investing $120M in new plant to make oligonucleotide APIs Life sciences company Agilent Technologies ($A) recently announced it would build a new U.S. plant that will more than double Agilent’s commercial manufacturing capacity for nucleic acid APIs, but the company was stingy with details. The company filled in the picture Wednesday after reporting earnings saying it will invest $120 million ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes